培氟沙星和头孢他定治疗成人下呼吸道感染的药物经济学分析

Pharmacoeconomic Analysis of Pefloxacin vs Ceftazidime in Treatment of Lower Respiratory Tract Infections in Adults

目的 :讨论不同抗生素治疗下呼吸道感染的经济效果。方法 :抽取本院50例下呼吸道感染患者 ,随机分为两组 ,根据不同治疗方案 (A组 :培氟沙星 ;B组 :头孢他定 ) ,运用药物经济学费用 -效果分析方法进行评价。结果 :A组和B组方案总成本分别为957 60元和1596 00元 ,其效果分别为84 %和92 %。每增加一个单位效果A组较B组节省79 80元。结论

OBJECTIVE:To discuss the economic efficiency of different antimicrobials in treatment of lower respiratory tract infections(LRTI) METHODS:50 cases of LRTI collected from this hospital were divided into two groups:A,pefloxacin;B,ceftazidime Evaluation was carried out with pharmacoeconomic cost-effectiveness analysis RESULTS:The total costs were 957 60 yuans and 1 596 00 yuans and the effective rates were 84% and 92% in group A and B respectively An increase of 1%effective rate in group A saved 79 80 yuans in comparison with that in group B CONCLUSION:The therapeutic scheme of pefloxacin seems to be the best one for treating LRTI